A Novel combination carrying A Hope for treatment of HIV - Salah, Sherif
20,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Although HIV-1 has been the most studied infectious agent in the last 30 years and Its widely believed that induction of neutralizing antibodies were sufficient for the protection against HIV . A novel mode of action of HIV infection assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protection against destruction by the cytotoxic CD8+ T-cells. This postulation differs from the ordinary rationales that depend on the role of neutralizing antibodies in controlling the HIV infection. In This book we introduce V20E as a new…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Although HIV-1 has been the most studied infectious agent in the last 30 years and Its widely believed that induction of neutralizing antibodies were sufficient for the protection against HIV . A novel mode of action of HIV infection assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protection against destruction by the cytotoxic CD8+ T-cells. This postulation differs from the ordinary rationales that depend on the role of neutralizing antibodies in controlling the HIV infection. In This book we introduce V20E as a new therapeutic immune peptides modality with a highly promising cure for HIV-1 disease and human immunodeficiency syndrome.
Autorenporträt
Dr. Sherif Salah is a Consultant of immunology,vet.¿Medicine Cairo University Holds a Ph. D.degree inimmunology, Innovator of three Pharmaceuticals inMarkets, published many articles and books in HIV,cancer andParkinson's & Alzheimer's journals and awarded fourpatents of invention on novel Biological molecules for treatment of HCV and HIV.